Prevalence, clinical characteristics and outcome in patients with chronic heart failure and diabetes

Chinese Medical Journal

Volumn 123, Issue 6, 2010, Pages 646-650

  Shi, Chuan ^a   Wang, Ling Jie ^a   Hu, Dan Feng ^a   Li, Jin Ping ^a   Zhu, Tian Qi ^a   Shan, Ying ^b   Zhao, Jian Rong ^c   Zhang, Feng Ru ^a   Shen, Wei Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

^c Luwan Hospital   (China)

Author keywords

Chronic heart failure; Diabetes mellitus; Medical treatment; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN A1C; NITRATE;

AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; RISK FACTOR; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; VENTRICULAR FUNCTION, LEFT;

EID: 77949790713     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.06.002     Document Type: Article

References (24)

1. Fonarow GC. An approach to heart failure and diabetes mellitus. Am J Cardiol 2005; 96: 47E-52E.
2. Cohen-Solar A, Beauvais F, Loqeart D. Heart failure and diabetes mellitus: epidemiology and management of an alarming association. J Card Fail 2008; 14: 615-625.
3. Erdmann E, Wilcox RG. Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failure. Eur Heart J 2008; 29:12-20.
4. Choy CK, Rodgers JE, Nappi JM, Haines ST. Type 2 diabetes mellitus and heart failure. Pharmacotherapy 2008; 28: 170-192.
5. Pazin-Filho P, Kottgen A, Bertoni AG, Russel SD, Selvin F, Rosamond WD, et al. HbA1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 2008; 51: 2197-2204.
6. Dai SM, Zhang S, Chen KP, Hua W, Wang FZ, Chen X, et al. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction. Chin Med J 2009; 122: 802-806.
7. Aguilar D, Bozkurt B, Ramasubbu K, Deswal A. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol 2009; 54: 422-428.
8. Hunt SA, Abranham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. J Am Coll Cardiol 2009; 53: e1-e90.
9. Zheng ZL, Mcissner A, Hausmann B, Alexander H, Simon R. Prognostic value of Doppler transmitral filling patterns in patients with chronic heart failure. Chin Med J 2004; 117: 176-182.
10. Preiss D, Zetterstrand S, McMurray JJ, Ostergren J, Michelson EL, Granger CB, et al. Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program. Diabetes Care 2009; 32: 915-920.
11. Gary R, Davis L. Diastolic heart failure. Heart Lung 2008; 37: 405-406.
12. Goode KM, John J, Rigby AS, Kilpatrick ES, Atkin SL, Braqadeesh T, et al. Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus. Heart 2009; 95: 917-923.
13. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2006; 291: 1489-1506.
14. Jagasia D, McNulty PH. Diabetes mellitus and heart failure. Congest Heart Fail 2003; 9: 133-139.
15. Stratmann B, Tschoepe D. Sweet heart-contributions of metabolism in the development of heart failure in diabetes mellitus. Exp Clin Endocrinol Diabetes 2008; 116 Suppl 1: S40-S45.
16. Skouri HN, Wilson Tang WH. The impact of diabetes on heart failure: opportunities for intervention. Curr Heart Fail Rep 2007; 4: 70-77.
17. From AM, Scott CG, Chen HH. Changes in diastolic dysfunction in diabetes mellitus over time. Am J Cardiol 2009; 103: 1463-1466.
18. Eshaghian S, Horwich TB, Fonarow GC. An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure. Am Heart J 2006; 151: e1-e6.
19. Burger AJ, Tsao L, Aronson D. Prognostic impact of diabetes mellitus in patients with acute decompensated heart failure. Am J Cardiol 2005; 95: 1117-1119.
20. Berry C, Brett M, Stevenson K, McMurray JJ, Norrie J. Nature and prognostic importance of abnormal glucose tolerance and diabetes in actue heart failure. Heart 2008; 94: 296-304.
21. Nichols GA, Koro CE, Gullion CM, Ephross SA, Brown JB. The incidence of congestive heart failure associated with antidiabetic therapies. Diabetes Metab Res Rev 2005; 21: 51-57.
22. Inzucchi SE. Metformin and heart failure: innocent until proven guilty. Diabetes Care 2005; 28: 2585-2587.
23. Giles TD. The patient with diabetes mellitus and heart failure: at-risk issues. Am J Med 2003; 115: 107S-110S.
24. Lukas MA. Beta blockade in diabetic heart failure. Heart Fail Clin 2006; 2: 89-99.